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Objectives: How to contain medical expenditures is a universal problem. The Japanese
government has increased patient co-payments to control it. The purpose of this study
is to clarify whether the increase in co-payments to 30 percent prevented patients with
hypertension or diabetes mellitus from receiving necessary care in the Employee Health
Insurance System.
Methods: The subjects were 211 patients with hypertension and 66 patients with
diabetes mellitus who regularly visited physicians from October 2001 to March 2002
and were defined as a cohort that needed health care, and their medical indicators
were examined between April and September 2002 (prestage) and between April and
September 2003 (poststage).
Results: In the hypertensive patients with no complications, the compliance rate was
89.9 percent and 88.0 percent in the prestage, and poststage, respectively, showing no
significant change. In the hypertensive patients with complications, the compliance rate
was 90.5 percent and 92.1 percent in the prestage and poststage, respectively, showing
no significant change. In the diabetic patients with complications, the compliance rate
was 77.5 percent and 79.2 percent, in the prestage and poststage, respectively, with no
significant change. In the diabetic patients with no complications, however, the compliance
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rate was 83.7 percent and 66.7 percent, in the prestage and poststage, respectively.
A significant decrease was observed among diabetic patients without complications.
Conclusions: Increasing co-payments reduced necessary preventive care in diabetic
patients without complications.
Keywords: Co-payments, Compliance, Hypertension, Diabetes mellitus, Health policy
The Employee Health Insurance System of Japan was es-
tablished for the employed in 1922 and was enacted by the
Health Insurance Law enforced in 1927 (13). Although the
medical expenses of the insured have been covered almost
fully, in principle, by the Health Insurance Plan for the Em-
ployee except for a fixed charge per medical services since
its establishment, a 10 percent co-payment was introduced in
October 1984, and it was increased to 20 percent in Septem-
ber 1997 (14). Also, because of the exacerbation of the fi-
nancial situation of the health insurance system due to causes
including the increase in the payments for the redistribution
system for the elderly health-care costs (4), the co-payments
were further increased to 30 percent in April 2003 (14).
In Japan, increasing the co-payment has been shown to
reduce medical expenditures (3;7). However, although it re-
duces need for medical services, it has also been suggested
to prevent early diagnosis and treatment of patients who
need treatment (9). Many of the studies on the effects of the
increase in co-payments suggested that physician visits con-
cerning milder disorders were deterred more as the burden on
the patients increased (1;10;12;15;16;18–20). Although hy-
pertension and diabetes mellitus cause mild symptoms, they
must be treated to prevent the occurrence of more-severe dis-
eases, such as cerebrovascular disorders and heart diseases.
We have reported that the effect of the introduction
of the 10 percent co-payment system in October 1984 ex-
erted only temporary effects on outpatient visits of patients
with hypertension (2) but that the increase in co-payments to
20 percent exerted permanent effects on the compliance rate
of highly compliant patients with hypertension or and dia-
betes mellitus (5;6). In a study of the effects of the raise of
the co-payments to 20 percent, we also demonstrated that the
consultation rate was lower but that the service days were
longer in a health insurance association with a lower stan-
dard monthly wage (6). This finding suggests that income
has an affect on visits to medical institutions and that in-
sured people with insufficient incomes visit physicians after
the diseases become more severe. The aim of this study was
to clarify whether the increase in co-payments to 30 per-
cent introduced in April 2003 prevented hypertensive and
diabetic patients from receiving necessary care by analyzing
their health care indicators in the Employee Health Insurance
System.
SUBJECTS AND METHODS
Of the individuals who lived in Fukuoka Prefecture and had
been affiliated with the A Health Insurance Association from
October 2001 to September 2003, 211 hypertensive patients
and 67 diabetic patients who regularly visited physicians
from October 2001 to March 2002 were defined as a cohort
that needed health care, and their medical indicators were
examined between April and September 2002 (prestage)
and between April and September 2003 (poststage). One
of the diabetic patients was excluded from analyses, because
the number of visits in the first stage was unusually high
(79 days); therefore, 211 hypertensive patients and 66 dia-
betic patients were analyzed.
Characteristics of the subjects were studied according to
the medical bills for outpatient services in March 2002. The
hypertensive patients who had cerebrovascular disorders, re-
nal disorders, or ischemic heart disease, and the diabetic
patients who had diabetic nephropathy, diabetic retinopathy,
diabetic neuropathy, ischemic heart disease, or cerebrovas-
cular disorders were regarded as having complications. The
ages of the subjects as of January 1 2002 were used for the
analyses.
The compliance rate, the mean of number of monthly
outpatient visits, the mean monthly medical expenditure per
patient were examined as indicators of health care. The com-
pliance rate was expressed as the percentage of the months in
which drugs were prescribed during the period in question.
Because drugs could not be prescribed beyond 1 month until
March 2002, the compliance could be estimated by exam-
ining the state of monthly visits of the patient. However, as
the amendment of the Health Insurance Law in April 2002
made it possible to prescribe drugs for 3 months, the state of
compliance thereafter was examined by checking monthly
bills for outpatient services.
The subjects were divided into those with complications
and those with no complications, and the values of each
parameter were compared stage by stage. Statistical analysis
was performed by paired t-test at the 0.05 level of signifi-
cance.
RESULTS
Table 1 shows the gender and age distribution of the
hypertensive patients. Complications were absent in 190
(90.0 percent) and present in 21 (10.0 percent). Of those
with no complications, 147 (77.4 percent) were men and 43
(22.6 percent) were women. Of those with complications,
nineteen (90.5 percent) were men and two (9.5 percent) were
women. As for complications, twelve (57.1 percent) had heart
diseases only, three (14.3 percent) had cerebrovascular dis-
orders only, three (14.3 percent) had kidney disorders only,
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Table 1. Age and Gender Distribution of Study Population with Hypertension
20–39 40–49 50–59 60–69 Total
Age strata n (%) n (%) n (%) n (%) n (%)
Complications (−)
Men 5 (3.4) 40 (27.2) 80 (54.4) 22 (15.0) 147 (77.4)
Women 1 (2.7) 12 (27.9) 28 (65.1) 2 (4.7) 43 (22.6)
Total 6 (3.2) 52 (27.4) 108 (56.8) 24 (12.6) 190 (100)
Complications (+)
Men 1 (5.3) 5 (26.3) 11 (57.9) 2 (10.5) 19 (90.5)
Women 0 (0.0) 0 (0.0) 2 (100.0) 0 (0.0) 2 (9.5)
Total 1 (4.8) 5 (23.8) 13 (61.9) 2 (2.5) 21 (100)
Table 2. Age and Gender Distribution of Study Population with Diabetes Mellitus
20–39 40–49 50–59 60–69 Total
Age strata n (%) n (%) n (%) n (%) n (%)
Complications (−)
Men 3 (7.5) 7 (17.5) 26 (65.0) 4 (10.0) 40 (87.0)
Women 0 (0.0) 2 (33.3) 4 (66.7) 0 (0.0) 6 (13.0)
Total 3 (6.5) 9 (19.6) 30 (65.7) 4 (8.7) 46 (100)
Complications (+)
Men 1 (5.9) 6 (26.3) 9 (52.9) 1 (5.9) 17 (85.0)
Women 0 (0.0) 1 (33.3) 2 (66.7) 0 (0.0) 3 (15.0)
Total 1 (5.0) 7 (35.0) 11 (55.0) 1 (5.0) 20 (100)
Table 3. Compliance Rates (%) for Hypertension and Diabetes Mellitus
Complications (−) (N = 190) Complications (+) (N = 21)
Hypertension Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 89.9 (23.2) Reference 90.5 (23.3) Reference
Poststage 88.0 (24.1) −1.9 (29.0) 92.1 (22.1) −1.6 (2.5)
Complications (−) (N = 46) Complications (+) (N = 20)
Diabetes mellitus Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 83.7 (29.9) Reference 77.5 (36.4) Reference
Poststage 66.7 (43.3) −17.0 (42.4)a 79.2 (31.9) 1.7 (4.2)
a; p < .01.
one (4.8 percent) had heart disease and kidney disorder, and
two (9.6 percent) had cerebrovascular disorder and kidney
disorder.
Table 2 shows the gender and age distribution of the
diabetic patients. Complications were absent in forty-six
(69.7 percent) and present in twenty (30.3 percent). Of those
with no complications, forty (87.0 percent) were men and
six (13.0 percent) were women. Of those with complications,
seventeen (85.0 percent) were men and three (15.0 percent)
were women. As for complications, three (15.0 percent) had
heart diseases only, one (5.0 percent) had a kidney disorder
only, five (25.0 percent) had retinopathy only, four (20.0 per-
cent) had neuropathy only, two (10.0 percent) had kidney
disorders and retinopathy, one (5.0 percent) had kidney dis-
orders and neuropathy, three (15.0 percent) had neuropathy
and retinopathy, and one (5.0 percent) had a kidney disor-
der, retinopathy, and neuropathy. Twenty patients were using
insulin, and none was undergoing dialysis.
Table 3 shows changes in the compliance rate. In the
hypertensive patients with no complications, the compliance
rate was 89.9 percent, and 88.0 percent in the prestage and
poststage, respectively, showing no significant change. In
the hypertensive patients with complications, the compli-
ance rate was 90.5 percent and 92.1 percent in the prestage
and poststage, respectively, showing no significant change.
In the diabetic patients with no complications, the compli-
ance rate was 83.7 percent and 66.7 percent, in the prestage
and poststage, respectively. A significant decrease was
observed between prestage and poststage. In the diabetic pa-
tients with complications, however, the compliance rate was
77.5 percent, and 79.2 percent, in the prestage, and poststage,
respectively, with no significant change.
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Table 4. Number of Outpatient Visits for Hypertension and Diabetes Mellitus
Complications (−) (N = 190) Complications (+) (N = 21)
Hypertension Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 1.6 (0.8) Reference 1.6 (0.7) Reference
Poststage 1.6 (1.3) −0.1 (1.4) 1.5 (0.6) −0.2 (2.8)a
Complications (−) (N = 46) Complications (+) (N = 20)
Diabetes mellitus Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 1.2 (0.6) Reference 1.2 (0.5) Reference
Poststage 1.1 (0.7) −0.1 (0.7) 1.2 (1.0) 0.0 (7.5)
a; p < .01.
Table 5. Outpatient Medical Costs for Hypertension and Diabetes Mellitus Unit: thousand
yen
Complications (−) (N = 190) Complications (+) (N = 21)
Hypertension Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 13.9 (7.1) Reference 19.9 (9.2) Reference
Poststage 13.9 (7.5) 0.0 (6.4) 19.2 (9.6) −0.7 (5.2)
Complications (−) (N = 46) Complications (+) (N = 20)
Diabetes mellitus Mean (SD) Difference (SD) Mean (SD) Difference (SD)
Prestage 17.0 (11.9) Reference 20.9 (11.4) Reference
Poststage 16.3 (12.5) −0.7 (9.1) 19.9 (12.9) −1.0 (10.0)
Table 4 shows changes in the number of monthly out-
patient visits. In the hypertensive patients with no compli-
cations, the number of outpatient visits was 1.6 and 1.6 in
the prestage and poststages, respectively, with no signifi-
cant change. In the hypertensive patients with complications,
it was 1.6 and 1.5, respectively, showing a significant de-
crease from the prestage to the poststage with the increase
in the co-payment rate from 20 percent to 30 percent. In
the diabetic patients with no complications, the number of
monthly outpatient visits was 1.2 and 1.1, respectively, with
no significant change. In the diabetic patients with compli-
cations, it was 1.2 and 1.2, respectively, with no significant
change.
Table 5 shows changes in the mean monthly medical ex-
penditure (in thousands of yen). In the hypertensive patients
with no complications, it was 13.9 ($116) and 13.9 ($116) in
the prestage and poststages, respectively, with no significant
change. In the hypertensive patients with complications, it
was 19.9 ($166) and 19.2 ($160), respectively, with no sig-
nificant change. In the diabetic patients with no complica-
tions, it was 17.0 ($142) and 16.3 ($136), in the prestage and
poststages, respectively, with no significant change. In the
diabetic patients with complications, it was 20.9 ($174) and
19.9 ($166), respectively, in the prestage and poststage with
no significant change.
DISCUSSION
Who should bear the increasing medical expenditures, how
they should be borne, and how they should be distributed
when the gross national product is not expected to increase
as it had in the past are important political problems of the
21st century shared by many countries. Especially in Japan,
unprecedented aging of the population is already causing
contemporary problems (11). Although need for medical ser-
vices increases steadily with aging of the population, the per-
centage of medical expenditures in the gross national product
cannot be increased infinitely.
Japan has chosen the policy of increasing the percentage
of the medical expenditure burdened by individual patients to
reduce the increases in medical expenditure overall. Whether
such a policy has been adequate from the viewpoints of fair-
ness and efficiency must also be evaluated. More specifically,
evaluation of whether increases in the percentage of medical
expenditure burdened by individual patients have affected
the patients’ attitude to necessary medical care is a very im-
portant problem. “Quantitative evidence” should be provided
to people to obtain their understanding about the increases in
co-payments burdened by individual patients.
The health indicators of 221 hypertensive patients and
66 diabetic patients who regularly consulted physicians from
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October 2001 to March 2002 were studied between April
and September 2002 (prestage), and between April and
September 2003 (poststage), when the co-payment rate was
raised to 30 percent.
We adopted medical indicators from 1 year to 6 months
before the co-payment increase as prestage, because we
found an increase in outpatient visits during the 6-month
period before the introduction of the 10 percent co-payment
in our previous study of the 1984 system change (2).
After the co-payment increase to 30 percent, the compli-
ance rate decreased significantly only in the diabetic patients
with no complications. The number of outpatient visits de-
creased significantly after the increase in co-payment only in
the hypertensive patients with complications, but no change
was observed in the medical cost either in the hypertensive
group or the diabetic group. The change in the number of
outpatient visits is a protective response to reduce the burden
of medical expenditure, and a decrease in the compliance rate
is considered to be due to discontinuation of treatment in pa-
tients who needed medications. Discontinuation of treatment
is a risky option for patients with complications, but no such
response was noted in this study. However, in the diabetic
patients with no complications, the compliance decreased
by 17.0 percent after the increase in the co-payment rate to
30 percent, suggesting an effect on the willingness of the
patients to request necessary care. This finding indicates that
the effect of the increase in co-payments from 20 percent to
30 percent differed according to the disease and the presence
or absence of complications.
At the increase in the co-payment rate to 20 percent,
we also studied its effects on outpatient visits of subjects
of the same health insurance association who were treated
for hypertension or diabetes mellitus at least once a month
from September 1996 to February 1997 (5;6). The study
demonstrated that the increase deterred both hypertensive
and diabetic patients from getting necessary care. The com-
pliance rate decreased as much as 8 percent. The subjects
of the present study are considered to be highly compliant,
because they continued to consult physicians even after the
increase in co-payments to 20 percent. The effect of the
increase in co-payments to 30 percent on diabetic patients
without complication is much more than that of the increase
in co-payments to 20 percent.
In July 2002, we conducted an investigation concerning
the increase in the co-payment rate scheduled to be enforced
in 2003 in the same health insurance association (8). In this
investigation, the subjects were asked to select the upper limit
of monthly patient co-payments that they could be burdened
for the treatment of hypertension or diabetes mellitus from
“2,500 yen ($21),” “5,000 yen ($42),” “7,500 yen ($63),”
“10,000 yen ($83),” “15,000 yen ($125),” and “above
15,000 yen ($125).” As a result, 67.9 percent of the insured
replied that the monthly patient co-payments that they could
afford was less than 5,000 yen ($42), and 5,000 yen ($42)
was found to be the upper limit of the bearable monthly co-
payments of the insured. It was reported that monthly out-
patient expenditure of the hypertensive patients was approx-
imately 15,000 yen ($125), and the 30 percent co-payment
was 4,500 yen ($38), which was less than 5,000 yen ($42)
(2). On the other hand, it was reported that monthly outpa-
tient expenditure of the diabetic patients was approximately
25,000 yen ($208), and the 30 percent co-payment was 7,500
yen ($63), which exceeded 5,000 yen ($42) (2). It is possi-
ble that 30 percent patient co-payments exceed the thresh-
old to reduce necessary care in highly complied diabetic
patients without complications. Although blood pressure
can be reduced consistently by medication in hypertensive
patients, therapeutic effects are small in diabetic patients
without changes in their lifestyle, including diet and exer-
cise. This finding may have resulted in the judgment of the
subjects that the effect of treatment is smaller for patient
costs in diabetes mellitus than in hypertension. However, it
would be difficult for diabetic patients with complications to
stop treatment, because they would fear that it would worsen
their complications.
Diabetic patients with no complications are less likely
to feel the benefit of health care because of the absence of
subjective complaints. However, these patients need exami-
nation and treatment, and treatment while the patients have no
subjective symptoms has been shown to prevent future com-
plications. An increase in co-payments to 30 percent may
cause deterioration of the health of workers with chronic dis-
orders with no marked subjective symptoms and lead to an
increase in the social cost. In the management of patients
with chronic disorders, who are less likely to realize the
effect of treatment, follow-up measures to promote regular
consultation after screening and to prevent discontinuation
of treatment should be considered also at each workplace.
There are limitations in the study. First, this study is a
time-sequence analysis, but the randomized controlled de-
sign is considered to be desirable for policy assessments.
However, a randomized controlled study was impossible,
because the increase in co-payment system was enforced as
a national policy under the insurance-for-all-people princi-
ple of Japan. Second, diagnoses of hypertension and diabetes
mellitus were based on health insurance claims. Finally, di-
rect medical costs for concurrent conditions such as the com-
mon cold or chronic gastritis could not be excluded from
the data on costs. However, these nondifferential misclas-
sifications likely occurred randomly, unassociated with the
prestage or the poststage (17).
CONCLUSIONS
The effect of the increase in the co-payment rate from
20 percent to 30 percent differed according to the disease and
the presence or absence of complications. The compliance
rate decreased significantly after the increase co-payments
to 30 percent only in the diabetic patients with no compli-
cations. An increase in the co-payments to 30 percent may
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cause deterioration of the health of workers who have dia-
betes mellitus with no marked subjective symptoms and lead
to an increase in the social cost.
Policy Implications
Increasing patient co-payments is one way to control ris-
ing health care costs. However, co-payments may reduce
the quality of care among working diabetic patients without
complications. The patients generally do not realize the pre-
ventive effects of the treatment. The condition of diabetes
mellitus of working individuals will deteriorate, leading to
higher medical and social costs in the long-term. Policy-
makers should understand the adverse influences of increas-
ing outpatient co-payments when developing cost-effective
medical policies.
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